Predictive performance of the Domino, Hijazi, and Clements models during low-dose target-controlled ketamine infusions in healthy volunteers

British Journal of Anaesthesia

Volumn 98, Issue 5, 2007, Pages 615-623

  Absalom, A R ^a   Lee, M ^a   Menon, D K ^a   Sharar, S R ^b   De Smet, T ^c   Halliday, J ^d   Ogden, M ^d   Corlett, P ^e   Honey, G D ^e   Fletcher, P C ^e  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Demed Engineering   (Belgium)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Anaesthetics, i.v., Ketamine; Pharmacokinetics

Indexed keywords

KETAMINE; ANESTHETIC AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; CALCULATION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INFUSION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LOW DRUG DOSE; MALE; METHODOLOGY; MODEL; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VENOUS BLOOD; VOLUNTEER; ADOLESCENT; BIOLOGICAL MODEL; BLOOD; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; EVALUATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PREDICTION AND FORECASTING; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANESTHETICS, DISSOCIATIVE; COGNITION; DRUG ADMINISTRATION SCHEDULE; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 34250318178     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aem063     Document Type: Article

References (39)

1. Himmelseher S, Durieux ME. Revising a dogma: Ketamine for patients with neurological injury? Anesth Analg 2005; 101: 524-34
2. Koppert W. Sittl R, Scheuber K, Alsheimer M, Schmelz M, Schuttler J. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 2003; 99: 152-9
3. Bell RF, Dahl JB, Moore RA, Kalso E. Perioperative ketamine for acute postoperative pain. Cochrane Database Syst Rev 2006: CD004603
4. Bourgoin A, Albanese J, Leone M, Sampol-Manos E, Viviand X, Martin C, Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain-injured patients. Crit Care Med 2005; 33: 1109-13
5. Hijazi Y, Bodonian C, Bolon M, Salord F, Boulieu R. Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury. Br J Anaesth 2003; 90: 155-60
6. White M, de Graaff P, Renshof B, van Kan E, Dzoljic M. Pharmacokinetics of 5(+) ketamine derived from target controlled infusion. Br J Anaesth 2006; 96: 330-4
7. Gray C, Swinhoe CF, Myint Y, Mason D. Target controlled infusion of ketamine as analgesia for TIVA with propofol. Can J Anaesth 1999; 46: 957-61
8. Katoh T, Suzuki A, Ikeda K. Electroencephalographic derivatives as a tool for predicting the depth of sedation and anesthesia induced by seyoflurane. Anesthesiology 1998; 88: 642-50
9. Luginbuhl M, Gerber A, Schnider TW, Petersen-Felix S, Arendt-Nielsen L, Curatolo M. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth Analg 2003; 96: 726-32
10. Rogers R, Wise RG, Painter DJ, Longe SE, Tracey I. An investigation to dissociate the analgesic and anesthetic properties of ketamine using functional magnetic resonance imaging. Anesthesiology 2004; 100 292-301
11. Honey RA, Turner DC, Honey GD, et al. Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory. Neuropsychopharmacology 2003; 28 2037-44
12. Honey RA, Honey GD, O'Loughlin C, et al. Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: An FMRI study. Neuropsychopharmacology 2004; 29: 1203-14
13. Honey GD, O'Loughlin C, Turner DC, Pomarol-Clotet E, Corlett PR, Fletcher PC. The effects of a subpsychotic dose of ketamine on recognition and source memory for agency: Implications for pharmacological modelling of core symptoms of schizophrenia. Neuropsychopharmacology 2006; 31: 413-23
14. Honey GD, Honey RA, Sharar SR, et al. Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: The effects of levels of processing at encoding and of the subsequent retrieval task. Psychopharmacology (Berl) 2005; 181: 445-57
15. Honey GD, Honey RA, O'Loughlin C, et al. Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: An fMRI study. Cereb Cortex 2005; 15: 749-59
16. Corlett PR, Honey GD, Aitken MR, et al. Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. Arch Gen Psychiatry 2006; 63: 611-21
17. Pomarol-Clotet E, Honey GD, Murray GK, et al. Psychological effects of ketamine in healthy volunteers. Phenomenological study. Br J Pychiatry 2006; 189: 173-9
18. Glen JB. The development of 'Diprifusor': A TCI system for propofol. Anaesthesia 1998; 53(Suppl 1): 13-21
19. Absalom A, Kenny GN. Current and future applications of target-controlled infusions. Drugs Today (Barc) 1999; 35: 823-34
20. Russell D. Intravenous anaesthesia: Manual infusion schemes versus TCI systems. Anaesthesia 1998; 53(Suppl 1): 42-5
21. Domino EF, Zsigmond EK, Domino LE, Domino KE, Kothary SP, Domino SE. Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay. Anesth Analg 1982; 61: 87-92
22. Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP. Psychedelic effects of ketamine in healthy volunteers: Relationship to steady-state plasma concentrations. Anesthesiology 1998; 88 82-8
23. Clements JA, Nimmo WS. Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth 1981; 53: 27-30
24. Kharasch ED, Labroo R. Metabolism of ketamine stereoisomers by human liver microsomes. Anesthesiology 1992; 77: 1201-7
25. Varvel JR, Donoho DL, Shafer SL. Measuring the predictive performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm 1992; 20: 63-94
26. Absalom A, Amutike D, Lal A, White M, Kenny GN. Accuracy of the 'Paedfusor' in children undergoing cardiac surgery or catheterization. Br J Anaesth 2003; 91: 507-13
27. Russell D, Wilkes MP, Hunter SC, Glen JB, Hutton P, Kenny GN. Manual compared with target-controlled infusion of propofol. Br J Anaesth 1995; 75: 562-6
28. Swinhoe CF, Peacock JE, Glen JB, Reilly CS. Evaluation of the predictive performance of a 'Diprifusor' TCI system. Anaesthesia 1998; 53 Suppl 1): 61-7
29. Wieber J, Gugler R, Hengstmann JH, Dengler HJ. Pharmacokinettics of ketamine in man. Anaesthesist 1975; 24: 260-3
30. Schuttler J, Kloos S, Schwilden H, Stoeckel H. Total intravenous anaesthesia with propofol and alfentanil by computer-assisted infusion. Anaesthesia 1988; 43(Suppl): 2-7
31. White PF, Schuttler J, Shafer A, Stanski DR, Horai Y, Trevor AJ. Comparative pharmacology of the ketamine isomers. Studies in volunteers. Br J Anaesth 1985; 57: 197-203
32. Idvall J, Ahlgren I, Aronsen KR, Stenberg P. Ketamine infusions: pharmacokinetics and clinical effects. Br J Anaesth 1979; 51 1167-73
33. Geisslinger G, Hering W, Kamp HD, Vollmers KO. Pharmacokinetics of ketamine enantionners. Br J Anaesth 1995; 75: 506-7
34. Schuttler J, Schuttler M, Kloos S, Nadstawek J, Schwilden H. Optimal dosage strategies in total intravenous anesthesia using propofol and ketamine. Anaesthesist 1991; 40: 199-204
35. Barvais L, Heitz D, Schmartz D. et al. Pharmacokinetic model-driven infusion of sufentanil and midazolam during cardiac surgery: Assessment of the prospective predictive accuracy and the quality of anesthesia. J Cardiothorac Vasc Anesth 2000; 14: 402-8
36. Gepts E, Shafer SL, Camu F, et al. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology 1995; 83: 1194-204
37. Marsh B, White M, Morton N. Kenny GN. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67: 41-8
38. Malacrida R, Fritz ME, Suter PM, Crevoisier C. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med 1992; 20: 1123-6
39. Shelly MP, Mendel L, Park GR. Failure of critically ill patients to metabolise midazolam. Anaesthesia 1987; 42: 619-26